PYRALVEX

This brand name is authorized in Ecuador, France, Singapore, Spain, UK.

Active ingredients

The drug PYRALVEX contains a combination of these active pharmaceutical ingredients (APIs):

1	Salicylic acid UNII O414PZ4LPZ - SALICYLIC ACID
	Salicylic acid has bacteriostatic and fungicidal actions, but it is its keratolytic properties which are important for this medicinal product. When applied externally it produces slow and painless destruction of the epithelium.
	Read more about Salicylic acid
2	Extractum rhei UNII YM64C2P6UX - RHEIN
	Read more about Anthraquinone glycosides

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A01AD	Other agents for local oral treatment	A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations
Discover more medicines within A01AD
A01AD05	Acetylsalicylic acid	A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AD Other agents for local oral treatment
Discover more medicines within A01AD05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	360670612
ES	Centro de información online de medicamentos de la AEMPS	24135, 2931-18-1-05, 2931-18-1-05IP
FR	Base de données publique des médicaments	63378561, 63938387
GB	Medicines & Healthcare Products Regulatory Agency	39891
SG	Health Sciences Authority	04226P